226 related articles for article (PubMed ID: 36231079)
21. Enhanced phosphoinositide 3-kinase(p110α) activity prevents diabetes-induced cardiomyopathy and superoxide generation in a mouse model of diabetes.
Ritchie RH; Love JE; Huynh K; Bernardo BC; Henstridge DC; Kiriazis H; Tham YK; Sapra G; Qin C; Cemerlang N; Boey EJ; Jandeleit-Dahm K; Du XJ; McMullen JR
Diabetologia; 2012 Dec; 55(12):3369-81. PubMed ID: 23001375
[TBL] [Abstract][Full Text] [Related]
22. P66Shc-Induced MicroRNA-34a Causes Diabetic Endothelial Dysfunction by Downregulating Sirtuin1.
Li Q; Kim YR; Vikram A; Kumar S; Kassan M; Gabani M; Lee SK; Jacobs JS; Irani K
Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2394-2403. PubMed ID: 27789474
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-451 exacerbates lipotoxicity in cardiac myocytes and high-fat diet-induced cardiac hypertrophy in mice through suppression of the LKB1/AMPK pathway.
Kuwabara Y; Horie T; Baba O; Watanabe S; Nishiga M; Usami S; Izuhara M; Nakao T; Nishino T; Otsu K; Kita T; Kimura T; Ono K
Circ Res; 2015 Jan; 116(2):279-88. PubMed ID: 25362209
[TBL] [Abstract][Full Text] [Related]
24. miR-340-5p Mediates Cardiomyocyte Oxidative Stress in Diabetes-Induced Cardiac Dysfunction by Targeting Mcl-1.
Zhu Y; Yang X; Zhou J; Chen L; Zuo P; Chen L; Jiang L; Li T; Wang D; Xu Y; Li Q; Yan Y
Oxid Med Cell Longev; 2022; 2022():3182931. PubMed ID: 35126811
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-34a regulates cardiac fibrosis after myocardial infarction by targeting Smad4.
Huang Y; Qi Y; Du JQ; Zhang DF
Expert Opin Ther Targets; 2014 Dec; 18(12):1355-65. PubMed ID: 25322725
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of miR-142-3p improves mitochondrial function in cardiac hypertrophy.
Liu BL; Cheng M; Hu S; Wang S; Wang L; Tu X; Huang CX; Jiang H; Wu G
Biomed Pharmacother; 2018 Dec; 108():1347-1356. PubMed ID: 30372837
[TBL] [Abstract][Full Text] [Related]
27. Down-regulation of miR-34a alleviates mesangial proliferation in vitro and glomerular hypertrophy in early diabetic nephropathy mice by targeting GAS1.
Zhang L; He S; Guo S; Xie W; Xin R; Yu H; Yang F; Qiu J; Zhang D; Zhou S; Zhang K
J Diabetes Complications; 2014; 28(3):259-64. PubMed ID: 24560136
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic overexpression of miR-92a-2-5p ameliorated cardiomyocyte oxidative stress injury in the development of diabetic cardiomyopathy.
Yu M; Sun Y; Shan X; Yang F; Chu G; Chen Q; Han L; Guo Z; Wang G
Cell Mol Biol Lett; 2022 Oct; 27(1):85. PubMed ID: 36209049
[TBL] [Abstract][Full Text] [Related]
29. Differential expression of dicer, miRNAs, and inflammatory markers in diabetic Ins2+/- Akita hearts.
Chavali V; Tyagi SC; Mishra PK
Cell Biochem Biophys; 2014 Jan; 68(1):25-35. PubMed ID: 23797610
[TBL] [Abstract][Full Text] [Related]
30. Cardiac-specific IGF-1 receptor transgenic expression protects against cardiac fibrosis and diastolic dysfunction in a mouse model of diabetic cardiomyopathy.
Huynh K; McMullen JR; Julius TL; Tan JW; Love JE; Cemerlang N; Kiriazis H; Du XJ; Ritchie RH
Diabetes; 2010 Jun; 59(6):1512-20. PubMed ID: 20215428
[TBL] [Abstract][Full Text] [Related]
31. Celastrol-Induced Suppression of the MiR-21/ERK Signalling Pathway Attenuates Cardiac Fibrosis and Dysfunction.
Cheng M; Wu G; Song Y; Wang L; Tu L; Zhang L; Zhang C
Cell Physiol Biochem; 2016; 38(5):1928-38. PubMed ID: 27160852
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of miR-21 alleviated cardiac perivascular fibrosis via repressing EndMT in T1DM.
Li Q; Yao Y; Shi S; Zhou M; Zhou Y; Wang M; Chiu JJ; Huang Z; Zhang W; Liu M; Wang Q; Tu X
J Cell Mol Med; 2020 Jan; 24(1):910-920. PubMed ID: 31680453
[TBL] [Abstract][Full Text] [Related]
33. Dec1 deficiency protects the heart from fibrosis, inflammation, and myocardial cell apoptosis in a mouse model of cardiac hypertrophy.
Li X; Le HT; Sato F; Kang TH; Makishima M; Zhong L; Liu Y; Guo L; Bhawal UK
Biochem Biophys Res Commun; 2020 Nov; 532(4):513-519. PubMed ID: 32896382
[TBL] [Abstract][Full Text] [Related]
34. Kallistatin reduces vascular senescence and aging by regulating microRNA-34a-SIRT1 pathway.
Guo Y; Li P; Gao L; Zhang J; Yang Z; Bledsoe G; Chang E; Chao L; Chao J
Aging Cell; 2017 Aug; 16(4):837-846. PubMed ID: 28544111
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic targeting of oxidative stress with coenzyme Q10 counteracts exaggerated diabetic cardiomyopathy in a mouse model of diabetes with diminished PI3K(p110α) signaling.
De Blasio MJ; Huynh K; Qin C; Rosli S; Kiriazis H; Ayer A; Cemerlang N; Stocker R; Du XJ; McMullen JR; Ritchie RH
Free Radic Biol Med; 2015 Oct; 87():137-47. PubMed ID: 25937176
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-221/222 Family Counteracts Myocardial Fibrosis in Pressure Overload-Induced Heart Failure.
Verjans R; Peters T; Beaumont FJ; van Leeuwen R; van Herwaarden T; Verhesen W; Munts C; Bijnen M; Henkens M; Diez J; de Windt LJ; van Nieuwenhoven FA; van Bilsen M; Goumans MJ; Heymans S; González A; Schroen B
Hypertension; 2018 Feb; 71(2):280-288. PubMed ID: 29255073
[TBL] [Abstract][Full Text] [Related]
37. Coenzyme Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db/db mouse model of type 2 diabetes.
Huynh K; Kiriazis H; Du XJ; Love JE; Jandeleit-Dahm KA; Forbes JM; McMullen JR; Ritchie RH
Diabetologia; 2012 May; 55(5):1544-53. PubMed ID: 22374176
[TBL] [Abstract][Full Text] [Related]
38. MLKL-mediated necroptosis is a target for cardiac protection in mouse models of type-1 diabetes.
Cao T; Ni R; Ding W; Ji X; Li L; Liao G; Lu Y; Fan GC; Zhang Z; Peng T
Cardiovasc Diabetol; 2022 Aug; 21(1):165. PubMed ID: 36030201
[TBL] [Abstract][Full Text] [Related]
39. miR-30c Mediates Upregulation of Cdc42 and Pak1 in Diabetic Cardiomyopathy.
Raut SK; Kumar A; Singh GB; Nahar U; Sharma V; Mittal A; Sharma R; Khullar M
Cardiovasc Ther; 2015 Jun; 33(3):89-97. PubMed ID: 25781190
[TBL] [Abstract][Full Text] [Related]
40. Rutin alleviates diabetic cardiomyopathy and improves cardiac function in diabetic ApoEknockout mice.
Huang R; Shi Z; Chen L; Zhang Y; Li J; An Y
Eur J Pharmacol; 2017 Nov; 814():151-160. PubMed ID: 28826911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
